Clinical Trials Browser

OTHER × Immunoglobulin Light-chain Amyloidosis × isatuximab × Clear all

NCT04754945 2026-02-18

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

Phase 1 Active not recruiting

Immunoglobulin Light-chain Amyloidosis